Replies to post #43516 on Relief Therapeutics Holding AG (RLFTF)

[soliloquy]

I believe you are in the ballpark with your assessment. I also believe with an approval from the FDA that those numbers would have to be reassessed . We really need strong outcomes in these trials so that the FDA must act appropriately (approval)! It seems nothing good happens fast enough with this stock. I would like to see an approval of some type and or very positive outcomes in are trials before Ram can go ahead with his Plan.

[theswordman]

So the ADR is a "representation" of the underlying stock. In this case 1 ADR will represent 150 shares of the underlying stock. So the ADR will trade as a reflection of the stock--not the other way around. So unless you believe that the stock will collapse--there will be no collapse in ADR price.

If underlying stock goes up a dime--the ADR should go up 15 dollars.

There will not be a massive disconnect between ADR and share price. If there was the arbitrage people will step in--make a fortune and things will synch again. There will always be some variance due to currency/rates but that should be major factor.

[Bill B]

Take a look at from this perspective. The market cap will not change with the switch to adrs. Should the company start producing revenue from any source the market cap will reflect the change whether it's denominated in either stock or adrs. Any improvement from current levels would be welcome and I frankly don't expect the share price to recover to the .50 range without an eua and given the complete and total focus of governments everywhere on shots to the exclusion of therapeutics that's not going to happen. A move up to 15 or 20 dollars per adr would be welcome.

[PennyWorld]

In hindsight I do need to quality one topic in my post. In his PRs, RAM keeps equating the ADR process with uplisting to the NASDAQ. So I tend to use the two topics interchangeably.

However.....Michael Miller (RLFTF IR rep) told me over the telephone a few weeks ago that investors should expect a LAG between reaching Levels and a NASDAQ uplisting. They are different events. So the way I understand it, RAM could reach ADR Level 3, but delay the NASDAQ uplisting for weeks or months.

Why does that minutia matter?? Because it's my understanding that we will NOT be FROCED to convert our RLFTF shares to ADRs (at the 1/150 ratio) until RAM actually performs the "Uplisting" to the NASDAQ. And just hitting Level 3 does not actually mean we get NAASDAQ uplisted. They are different events/processes.

This is the way I understand how things works. Anyone is free to correct me if I'm wrong on any of this. This is my understanding based on my conversations with both Michael Miller (RLFTF IR) as well as OTC specialists.